000756 新华制药
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资58,5250.57%58,19158,73058,57257,154
投资性房地产28,895-2.76%29,71531,79733,90948,354
固定资产3,679,116-2.75%3,783,2523,511,4613,325,9453,447,889
在建工程381,6974.24%366,171781,095730,545545,895
无形资产557,539-3.44%577,399565,038494,937474,107
商誉0--0000
其他非流动资产311,346-7.75%337,495344,640327,925234,432
5,017,118-2.62%5,152,2235,292,7614,971,8334,807,831

流动资产
货币资金1,276,588-8.59%1,396,4831,245,023918,3341,158,742
应收账款1,113,48929.12%862,389868,204699,878761,259
存货1,215,751-7.76%1,318,1001,272,8571,312,9841,211,987
其他流动资产445,982-2.30%456,502340,756383,138324,971
4,051,8100.45%4,033,4733,726,8403,314,3343,456,959

流动负债
短期借款454,7644.87%433,639580,156283,959118,023
应付票据518,161-1.45%525,784444,140511,431491,025
应付帐款711,916-9.35%785,335714,540666,413599,056
其他流动负债611,922-42.62%1,066,4451,056,7791,024,1981,950,382
2,296,764-18.30%2,811,2022,795,6142,486,0003,158,486
流动资产净值1,755,04643.59%1,222,270931,226828,333298,474
资产总额减流动负债6,772,1646.24%6,374,4936,223,9875,800,1665,106,305

非流动负债
长期借款942,32035.52%695,320771,541799,400545,656
应付债券0--0000
其他非流动负债233,9834.72%223,447234,946225,013211,085
1,176,30328.03%918,7671,006,4871,024,413756,741

总权益
    实收股本696,6831.00%689,777682,408674,683669,627
    储备项目4,653,1042.97%4,518,9774,309,1813,878,4213,456,647
股东权益5,349,7882.71%5,208,7534,991,5894,553,1044,126,274
非控股权益246,074-0.36%246,973225,912222,649223,290